Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Citreoviridin

Citreoviridin

Catalog No.GC41514

Citreoviridina, una toxina de Penicillium citreoviride NRRL 2579, inhibe la Na+/K+-ATPasa sinaptosÓmica cerebral mientras que en los microsomas, tanto la Na+/K+-ATPasa como la Mg2+-ATPasa son significativamente estimulados de una manera dependiente de la dosis.

Products are for research use only. Not for human use. We do not sell to patients.

Citreoviridin Chemical Structure

Cas No.: 25425-12-1

Tamaño Precio Disponibilidad Cantidad
500μg
47,00 $
Disponible
1mg
82,00 $
Disponible
5mg
312,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Citreoviridin, a toxin from Penicillium citreoviride NRRL 2579, inhibits brain synaptosomal Na+/K+-ATPase whereas in microsomes, both Na+/K+-ATPase and Mg2+-ATPase activities are significantly stimulated in a dose-dependent manner[1]. Citreoviridin inhibits cell proliferation and enhances apoptosis of human umbilical vein endothelial cells[2].

References:
[1]. Datta SC, et al. Effect of citreoviridin, a mycotoxin from Penicillium citreoviride, on kinetic constants of acetylcholinesterase and ATPase in synaptosomes and microsomes from rat brain. Toxicon. 1981;19(4):555-62.
[2]. Hou H, et al. Citreoviridin inhibits cell proliferation and enhances apoptosis of human umbilical vein endothelial cells. Environ Toxicol Pharmacol. 2014 Mar;37(2):828-36.

Reseñas

Review for Citreoviridin

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Citreoviridin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.